Harnessing CD4⁺ T cell responses in HIV vaccine development

Nat Med. 2013 Feb;19(2):143-9. doi: 10.1038/nm.3054. Epub 2013 Feb 6.

Abstract

CD4(+) T cells can perform a panoply of tasks to shape an effective response against a pathogen. Limited attention has been paid to the potential importance of functional CD4(+) T cell responses in the context of the development of next-generation vaccines, including HIV vaccines. Many CD4(+) T cell functions are newly appreciated and only partially understood. A workshop was held as a forum to bring together a small group of experts to exchange ideas on the role of CD4(+) T cells in developing durable functional antibody responses, via follicular helper T cells, as well as on the roles of CD4(+) T cells in other aspects of protective immunity. Here we discuss whether CD4(+) T cell responses may represent a beneficial component of an efficacious HIV vaccine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • AIDS Vaccines / immunology*
  • Antibodies, Neutralizing / biosynthesis
  • CD4-Positive T-Lymphocytes / immunology*
  • HIV Antibodies / biosynthesis
  • Humans
  • Receptors, CXCR5 / analysis

Substances

  • AIDS Vaccines
  • Antibodies, Neutralizing
  • CXCR5 protein, human
  • HIV Antibodies
  • Receptors, CXCR5